Irene Pharma, a leading pharmaceutical manufacturing company in Ahmedabad, Gujarat, India, focuses on providing the most nutritional value possible through a diverse range of high-quality healthcare products. The company's high-tech manufacturing....
Mukesh Ambani's group is venturing into genetic mapping, hoping to make a healthcare trend spearheaded by disruptive US startups like 23andMe more affordable and widespread in India's expanding consumer market...
Bristol Myers Squibb (BMS) has become the latest drug maker to announce its intent to set up a state-of-the-art centre in India to support its global drug development, digital innovation and technology plans...
AstraZeneca India has declared its entry into the Indian market for rare disease therapy. The regulatory approval of its 'Selumetinib' shows the company's commitment to bringing first-in-class, science-based therapies to patients in India...
Zydus Lifesciences said it has received approval from the US health regulator to market a generic medication to prevent and treat blood clots. The company has received approval from the US Food and Drug Administration (USFDA) to market Apixaban...
The Wall Street Journal reported on Sunday that Pfizer Inc is in early-stage talks to acquire cancer drugmaker Seagen Inc in a multibillion-dollar deal, citing people familiar with the matter...
Medijourn, India's biggest healthcare facilitator and super aggregator in the global medical value travel industry, has announced a partnership with 8chili Inc., a deep-tech start-up based in California that is developing the underlying...
Venus Remedies announced on Monday that it has obtained good manufacturing practises (GMF) certification from the Saudi drug regulator for its Baddi, Himachal Pradesh, production facilities...
Dr Reddy's Laboratories Ltd announced that its subsidiary has entered into a definitive agreement to acquire Australia-based Mayne Pharma Group Limited's US generic prescription product portfolio for USD 105 million. According to a press release...
The US Food and Drug Administration (FDA) has granted an emergency use authorization (EUA) for the first over-the-counter (OTC) at-home diagnostic test capable of distinguishing and detecting influenza A and B, also known as the flu, and...
, CDSCO.jpg)
